Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.

American journal of clinical pathology - 1 Apr 2008

Rausei-Mills Veronica, Chang Karen L, Gaal Karl K, Weiss Lawrence M, Huang Qin

Abstract excerpt

Acute myeloid leukemia (AML) with normal cytogenetics represents approximately 40% to 50% of de novo AML. This heterogeneous AML subgroup constitutes the single largest cytogenetic group with an intermediate prognosis. Previous studies have suggested that the Fms-like tyrosine kinase-3 internal tandem duplication (FLT3/ITD) mutation-positive de novo AML may represent a distinctive subgroup of AML. We analyzed the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD7
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to California

Share to Cell Transformation, Neoplastic

Share to fms-Like Tyrosine Kinase 3

Share to Leukemia, Myeloid, Acute

Share to Survival Rate

Share to Tandem Repeat Sequences

Source

Identifiers

PMID: 18343790
DOI: 10.1309/NRTX9AKXHR5JBT93

Genes

FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.PMID 18343790Read ↗

Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations.Semantic proximity Read ↗

Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in <i>de novo</i> acute myeloid leukaemiaSemantic proximity Read ↗

Correlation of FLT3 mutations with expression of CD7 in acute myeloid leukemia.Semantic proximity Read ↗

Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features.Semantic proximity Read ↗

Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.Semantic proximity Read ↗

EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.Semantic proximity Read ↗

Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.Semantic proximity Read ↗

Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.Semantic proximity Read ↗

CD7 expression in acute myeloid leukemia.Semantic proximity Read ↗

Prognostic Implications of CD14 Antigen Expression in De Novo Acute Myeloid LeukemiaSemantic proximity Read ↗

CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.Semantic proximity Read ↗

Biological characteristics of CD7(+) acute leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.